Shingo Yogosawa Selected Research

Shingo Yogosawa Research Topics

Disease

14	Neoplasms (Cancer) 05/2013 - 01/2002
7	Colonic Neoplasms (Colon Cancer) 03/2016 - 05/2007
3	Carcinogenesis 11/2007 - 01/2002
2	Ovarian Neoplasms (Ovarian Cancer) 09/2017 - 01/2015
2	Osteosarcoma (Osteogenic Sarcoma) 04/2006 - 05/2005
1	Amebiasis (Amoebiasis) 01/2015
1	Carcinoma (Carcinomatosis) 01/2015
1	Endometrial Neoplasms (Endometrial Cancer) 05/2013
1	Retinoblastoma (Glioblastoma, Retinal) 05/2007
1	Neuroblastoma 07/2006
1	Alopecia (Baldness) 04/2006
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2005
1	Hepatocellular Carcinoma (Hepatoma) 01/2004
1	Liver Neoplasms (Liver Cancer) 01/2004
1	Neoplasm Metastasis (Metastasis) 01/2004

Drug/Important Bio-Agent (IBA)

3	Histone Deacetylases (Histone Deacetylase)IBA 09/2017 - 04/2010
3	Histone Deacetylase InhibitorsIBA 09/2017 - 05/2005
3	PhytochemicalsIBA 12/2012 - 11/2009
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2016 - 03/2012
2	brassininIBA 03/2016 - 03/2012
2	CaspasesIBA 01/2015 - 07/2006
2	Pharmaceutical PreparationsIBA 01/2015 - 04/2006
2	CurcuminIBA 12/2012 - 01/2004
2	Proteins (Proteins, Gene)FDA Link 04/2010 - 01/2005
2	FlavonoidsIBA 01/2005 - 01/2004
2	Carotenoids (Carotene)IBA 01/2004 - 01/2002
1	Fluorouracil (Carac)FDA LinkGeneric 09/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2017
1	AlkaloidsIBA 01/2015
1	Cisplatin (Platino)FDA LinkGeneric 01/2015
1	EmetineIBA 01/2015
1	PlatinumIBA 01/2015
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 05/2013
1	2- (2- methoxy- 4- nitrophenyl)- 3- (4- nitrophenyl)- 5- (2,4- disulfophenyl)- 2H tetrazolium monosodium saltIBA 05/2013
1	methyl-3-methoxy-4-hydroxystyryl ketoneIBA 12/2012
1	indoleIBA 03/2012
1	Biological ProductsIBA 03/2012
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 04/2010
1	CCAAT-Enhancer-Binding ProteinsIBA 04/2010
1	PPAR gammaIBA 04/2010
1	LigandsIBA 04/2010
1	cucurbitacin BIBA 04/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2010
1	TriterpenesIBA 04/2010
1	GenisteinIBA 11/2009
1	Cyclin-Dependent Kinase Inhibitor p16IBA 11/2007
1	N- (3- (5- (4- bromo- 2- fluorophenylamino)- 3- cyclopropyl- 8- methyl- 2,4,7- trioxo- 3,4,7,8- tetrahydro- 2H- pyrido(2,3- d)pyrimidin- 1- yl)phenyl)methanesulfonamideIBA 11/2007
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2007
1	pyrimidineIBA 11/2007
1	Gefitinib (Iressa)FDA Link 05/2007
1	Retinoblastoma ProteinIBA 05/2007
1	Caspase 3 (Caspase-3)IBA 07/2006
1	Synthetic DrugsIBA 07/2006
1	lembehyne AIBA 07/2006
1	lysocellinIBA 04/2006
1	Etoposide (VP 16)FDA LinkGeneric 04/2006
1	alopestatinIBA 04/2006
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2006
1	QuercetinIBA 11/2005
1	ApigeninIBA 01/2005
1	Peroxynitrous Acid (Peroxynitrite)IBA 01/2004
1	nobiletinIBA 01/2004
1	AntioxidantsIBA 01/2004
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2004
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2004
1	beta Carotene (Betacarotene)FDA Link 01/2002
1	astaxanthine (astaxanthin)IBA 01/2002
1	LuteinIBA 01/2002
1	LycopeneIBA 01/2002
1	Beta-CryptoxanthinIBA 01/2002
1	trans-sodium crocetinate (crocetin)IBA 01/2002
1	(all-E) phytoeneIBA 01/2002
1	alpha-caroteneIBA 01/2002
1	fucoxanthinIBA 01/2002
1	capsanthinIBA 01/2002
1	ZeaxanthinsIBA 01/2002

Therapy/Procedure

2	Chemoprevention 11/2009 - 01/2002
2	Therapeutics 11/2009 - 07/2006